Ara A. Vaporciyan
Papers
8
Total Citations
335
H-Index
8
About
Dr. Ara A. Vaporciyan is a leading thoracic surgeon whose research bridges cutting-edge immunotherapy, robotic surgery, and surgical education. He is best known for his pivotal contributions to the NEOSTAR trial, demonstrating that neoadjuvant nivolumab, alone or with ipilimumab, yields promising surgical outcomes in non-small cell lung cancer—work that has garnered over 140 citations across multiple publications. His expertise in minimally invasive techniques is evident in landmark studies on robotic-assisted lobectomy and anatomic segmentectomy, which have shaped patient selection and procedural trends, collectively cited more than 120 times. Beyond the operating room, Dr. Vaporciyan is a dedicated educator, critically examining gaps in thoracic surgery residency training and addressing the unique challenges of teaching millennial learners, with his work on generational differences in surgical education cited over 60 times. He also leads efforts in perioperative optimization, notably developing enhanced recovery protocols that sustainably reduce opioid prescriptions. With a career defined by innovation in oncologic surgery, robotic precision, and trainee mentorship, Dr. Vaporciyan’s research continues to influence both clinical practice and the next generation of thoracic surgeons.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Are There Gaps in Current Thoracic Surgery Residency Training Programs?43 citations · 2016
- 4
- 5
- 6
- 7Surgeon teachers and millennial learners: Bridging the generation gap18 citations · 2020
- 8